EYPT

NASDAQ open

EyePoint

0.26 USD
▼-0.00-0.98%
盘后 0.37 0.00%
2026-11-20
市值
$26.65M
市盈率
—
EPS
-3.97
股息率
—
52 周区间
0.26 – 19.11
成交量
290.17K
Beta
1.91
目标价
8.31
52W 低 0.2652W 高 19.11
价格走势

公司简介

EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is DURAVYU, an investigational sustained delivery treatment for vascular endothelial growth factor mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 3 clinical trials for wet ...

关联新闻